Gwangmyeong, South Korea

Jong Wook Lee

This inventor holds 14 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Yuhan Corporation, Dong-A Pharmaceutical Co., Ltd, Other. Active years: 1992-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jong Wook Lee. Retrieved from https://idiyas.com/inventor/jong-wook-lee-jh4qhjkg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 57.1

Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 93(Granted Patents)


Location History:

  • Kyounggi, KR (1992)
  • Kyonggi, KR (1992)
  • Kyunggi-do, KR (2002)
  • Kyonggi-do, KR (2003)
  • Kwacheon-Si, KR (1998 - 2006)
  • Kwacheon, KR (1992 - 2008)

Company Filing History:


Years Active: 1992-2008

Loading Chart...
Areas of Expertise:
Pyrimidine Derivatives
Monoclonal Antibody
HBV S-Surface Antigen
Cephalosporin Derivatives
Dihydropyridine Derivatives
Dithioketene Derivatives
Quinazoline Derivatives
1-Phenylpiperidin-3-One
Chemopreventive Compounds
Pharmaceutical Compositions
14 patents (USPTO):Explore Patents

Title: Innovations of Jong Wook Lee

Introduction

Jong Wook Lee is a prominent inventor based in Kwacheon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of 14 patents. His work focuses on developing innovative compounds and processes that have potential therapeutic applications.

Latest Patents

Among his latest patents is the invention of 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof. This invention provides 1-phenylpiperidin-3-one derivatives and pharmaceutically acceptable salts that exhibit cysteine protease inhibitory activity. Additionally, he has developed pharmaceutical compositions containing these derivatives as active ingredients, along with processes for their preparation. Another notable patent involves the variable region of a monoclonal antibody against the HBV S-surface antigen and a gene encoding the same. This invention relates to a variable region of the monoclonal antibody against the S-surface antigen of the hepatitis B virus, a recombinant vector containing the gene, and a transformant obtained from the recombinant vector.

Career Highlights

Jong Wook Lee has worked with Yuhan Corporation, a leading pharmaceutical company in South Korea. His experience in this organization has contributed to his expertise in drug development and innovation.

Collaborations

Some of his notable coworkers include Jeong S Chae and Bong Yong Lee, who have collaborated with him on various projects.

Conclusion

Jong Wook Lee's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…